Fudan University: Neoplasms trials

The registry lists 32 Neoplasms studies with Fudan University as lead sponsor. 15 are open to participants now and 0 have results posted.

Early Phase 1 2Phase 1 2Phase 2 8Phase 3 8No phase 13(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• FAPI-Guided Radiotherapy With Cadonilimab and Standard Chemotherapy for Colorectal Peritoneal Metastasis: A Phase III Randomized Controlled Trial (TORHC-PM02)RecruitingNCT07815834Phase 3
• Real-World Study of Young Patients With Solid Tumors in ChinaRecruitingNCT07708935
• Epidemiology and Prognostic Analysis of Chinese Cancer Patients With Cancer-related FatigueRecruitingNCT07656324
• DV+BCG in HER2-Expressing, BCG-Naïve High-Risk NMIBCRecruitingNCT07207824Phase 3
• Predicting Gastric Neoplasia in Patients with High-risk Endoscopic FeaturesNot yet recruitingNCT06853509
• Study on the Safety and Efficacy of Intravenous Administration of IDOV-SAFETM in the Treatment of Advanced Solid TumorsRecruitingNCT06718946Early Phase 1
• Study on the Safety and Efficacy of Intratumoral Administration of IDOV-SAFETM in the Treatment of Advanced Solid TumorsNot yet recruitingNCT06713148Early Phase 1
• A Clinial Trial of Lutetium [177Lu]-FAP-75 for the Treatment of Patients With Advanced Solid TumorsNot yet recruitingNCT06553846Phase 1
• A Clinical Research About CD70-targeted CAR-NKT Cells Therapy Advanced Malignant Solid TumorsRecruitingNCT06394622Phase 1
• Comparison of Kimura Versus Warshaw Technique for Laparoscopic Spleen-Preserving Distal PancreatectomyNot yet recruitingNCT06167421Not applicable
• Cryoablation Combined with Tislelizumab Plus Lenvatinib in Previously Treated Solid Tumors (CASTLE-11)RecruitingNCT06032845Phase 2
• Postoperative Effects of Different Enterostomy ApproachesRecruitingNCT05853094Not applicable
• Nimotuzumab in EGFR Highly Expressed Pancreatic Neuroendocrine NeoplasmsNot yet recruitingNCT05316480Phase 2
• Long-term Survivorship of Discharged Patients With Malignant Tumor Based on Single-institutional Cancer RegistryRecruitingNCT04996732
• Observational Prospective Study of Immune Checkpoint Inhibitors for Solid NeoplasmsRecruitingNCT04766515
• Comparing 18F-FAPI PET-Guided Abdominal Radiotherapy Combined With Second-Line Standard Therapy and Cadonilimab Versus Second-Line Standard Therapy in Colorectal Cancer With Peritoneal MetastasisActive, not recruitingNCT07079462Phase 2
• Pancreatic Fistula After Minimally Invasive EnucleationCompletedNCT06557408
• Minimally Invasive Pancreatic Enucleation With Main Pancreatic Duct Exposure, Repair or ReconstructionCompletedNCT06024343Not applicable
• Primary Tumor Burden Score:A Novel Staging Parameter for ESCC After nCRTCompletedNCT05839002
• Study on the Correlation Between Immunoglobulin and Liposomal Doxorubicin in VivoStatus unknownNCT05354076Phase 2
• Camrelizumab Combined With Trastuzumab and Chemotherapy in Patients With HER2-positive Advanced Colorectal CancerStatus unknownNCT05193292Phase 2
• Value of ctDNA in the Treatment of Multiple Primary CancersStatus unknownNCT05164510Phase 2
• Single-cell Sequencing and Establishment of Models in Neuroendocrine NeoplasmStatus unknownNCT04927611
• Study on Predictive Biomarkers of Neoadjuvant Chemoradiotherapy for Rectal CancerStatus unknownNCT04227886
• The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric CancerStatus unknownNCT03889626Phase 3
• Chidamide Combined With R-GDP in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)Status unknownNCT03373019Phase 2
• Megestrol Acetate Plus LNG-IUS in Young Women With Early Endometrial CancerCompletedNCT03241914Phase 2/3
• The Study of Targeted NY-ESO-1 T Cell Receptor (TCR) Genetic Modified Autologous T Cells Treatment of Advanced Solid TumorsStatus unknownNCT03047811Not applicable
• Clinical Trial of Adjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy Compared With Adjuvant Chemotherapy Alone in Patients With Gallbladder Carcinoma and Extrahepatic CholangiocarcinomaStatus unknownNCT02798510Phase 3
• Nonstented Stump-closed vs Duct-to-Mucosa Pancreaticojejunostomy After PancreaticoduodenectomyCompletedNCT01731821Phase 3
• New Adjuvant Chemotherapy of Asymptomatic Resectable Primary Lesion With Unresectable Liver-limited MetastasesCompletedNCT01307878Phase 3
• Trial of Preoperative Hepatic and Regional Arterial Chemotherapy (PHRAC) to Prevent Postoperative Liver Metastasis of Colorectal CancerStatus unknownNCT00643877Phase 3